Welcome to our dedicated page for Ig Acquisition news (Ticker: IGAC), a resource for investors and traders seeking the latest updates and insights on Ig Acquisition stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ig Acquisition's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ig Acquisition's position in the market.
Invest Green Acquisition Corporation (NASDAQ:IGACU / IGAC / IGACR) priced a $150.0 million initial public offering of 15,000,000 units at $10.00 per unit on November 24, 2025. Units are expected to begin trading on the Nasdaq Global Market as IGACU on November 25, 2025, with Class A shares and rights expected to trade as IGAC and IGACR once separated. The offering is expected to close on November 26, 2025, subject to customary conditions. The company will target business combinations in renewable energy, sustainable finance and nuclear energy. Underwriters have a 45-day option for 2,250,000 additional units to cover over-allotments.
FAQ
What is the market cap of Ig Acquisition (IGAC)?
